Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Why Startups Are Now Ripe for Acquisition

    4. September 2025

    Senseonics to Take Over Eversense 365 Commercialization from Ascensia

    4. September 2025

    Meroka Launches With $6M to Fight Healthcare Corporate Consolidation with Employee-Owned Practices

    4. September 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Senseonics to Take Over Eversense 365 Commercialization from Ascensia
    News

    Senseonics to Take Over Eversense 365 Commercialization from Ascensia

    HealthradarBy Healthradar4. September 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Senseonics to Take Over Eversense 365 Commercialization from Ascensia
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Senseonics to Take Over Eversense 365 Commercialization from Ascensia

    What You Should Know: 

    – Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization and distribution of its Eversense 365 and future products to Senseonics. Since 2020, Ascensia, a member of PHC Group, has held the exclusive worldwide distribution rights for Eversense products.

    This strategic move is set to take effect in the U.S. on January 1, 2026, with Senseonics assuming responsibility for all global sales, marketing, and commercialization. Brian Hansen, who has served as President of CGM at Ascensia, will join Senseonics as Chief Commercial Officer on the same day.

    A Strategic Shift for Accelerated Growth

    Eversense 365 is the world’s first and only year-long continuous glucose monitor. According to Tim Goodnow, PhD, President and CEO of Senseonics, the go-to-market approach for Eversense is diverging from Ascensia’s core business, and the product is at an inflection point that requires fully dedicated commercial efforts and tight vertical integration. By bringing commercialization in-house, the company believes it can achieve accelerated growth and realize the product’s full potential faster than under the current structure.

    Financial Outlook and Operational Benefits

    The planned transition is expected to position Senseonics to better meet the needs of payers, providers, and patients, while also improving efficiency and agility. Owning the commercial channel is also expected to increase Senseonics’s topline revenue and expand margins by eliminating the revenue sharing with Ascensia.

    Senseonics expects to see immediate revenue improvement and a gross margin expansion to 50% in 2026, with a planned increase to more than 70% gross margins at scale. These investments in the commercial organization would be funded in part by the improved margins, as well as from an expanded $100 million non-dilutive debt facility with Hercules Capital, Inc..

    Senseonics continues to expect full-year 2025 global net revenue to be approximately $34-38M. This outlook assumes a doubling of the global patient base during 2025, with two-thirds of the revenue generated in the second half of the year. Full-year 2025 gross margins are expected to be between 32.5% and 37.5%, with cash used in operations projected to be approximately $60M.



    Source link

    Ascensia Commercialization Continuous Glucose Monitoring (CGM) Diabetes Management Eversense Senseonics
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleMeroka Launches With $6M to Fight Healthcare Corporate Consolidation with Employee-Owned Practices
    Next Article Why Startups Are Now Ripe for Acquisition
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Meroka Launches With $6M to Fight Healthcare Corporate Consolidation with Employee-Owned Practices

    4. September 2025
    News

    Philips SpeechLive Partners with Corti to Integrate Ambient AI for Clinical Documentation

    4. September 2025
    News

    Medable Launches Agent Studio, the First Agentic AI Platform for Life Sciences

    4. September 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202560 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202523 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202519 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20259 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202560 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202523 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.